News Articles for Osteopore

Bulls N' Bears ASX Runners of the Week is… Lumos Diagnostics, after the company signed an exclusive diagnostics supply agreement for the US, valued at up to $487 million. Tali Resources bucked the IPO trend by flying out of the gates on day-one of listing on its West Arunta copper potential. Osteopore Ltd's 3D-printed implants got the nod for market distribution in Switzerland and ClearVue unveiled stellar trial results for its solar vaccuum-insulated glazing units in Hong Kong.

Our weekly appointments wrap includes Carina Tan-Van Baren, Russell Gibbs, Yujing Lim, James Cox, Glenn Poole, Charlie Gunningham, Danelle Cross, Anna Shave, Oliver Bazzani, Eliza Carbines, Sandy Chong, Jemma Iles, Kent Matla, Clare Mould, Faz Pollard and Mette Wendler.

Perth-registered Singaporean regenerative medtech company Osteopore has struck an exclusive distribution agreement with global medtech leader Zimmer Biomet.

This week's Bulls N' Bears ASX Runner of the Week is … The Calmer Co International. Its shares jumped 185 per cent on the back of a significant spike in online and retail sales for its products to see it join fellow movers and shakers Firetail Resources, Osteopore and INOVIQ.

This week's Bulls N' Bears Runner of the Week is … Osteopore. Its share price hiked up more than 478 per cent to join mining movers and shakers Base Resources, Orion Minerals and Rincon Resources.

This week's Bulls N' Bears ASX Runner of the Week is… Osteopore. Its share price surged more than 1060 per cent after announcing a deal to sell its regenerative bone implant technology into Singaporean and Vietnamese markets. Osteopore joins fellow market movers and shakers this week Allup Silica and Many Peaks Minerals.

Our weekly appointments wrap includes Paul Larsen, Stephen Daly, Jodie Perram, Leigh Dyson, Scott Lowe, Bianca Sandri, Felicity Gooding, Shelley Cable and Michael Keenan.

Singapore- and Perth-based medical technology company Osteopore has appointed former federal cabinet minister Michael Keenan to its board and promoted two of its senior employees.

A Perron Institute spinout focused on reducing brain damage caused by strokes listed on the ASX this morning, with its share price rising 50 per cent.

Singapore and Perth-based biotech company Osteopore has begun life on the ASX today with a sharp share price surge, following a $5.25 million initial public offering.